175 related articles for article (PubMed ID: 33008876)
41. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
[TBL] [Abstract][Full Text] [Related]
42. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
Front Immunol; 2021; 12():619932. PubMed ID: 33868236
[TBL] [Abstract][Full Text] [Related]
43. Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.
Knutson KL; Maurer MJ; Preston CC; Moysich KB; Goergen K; Hawthorne KM; Cunningham JM; Odunsi K; Hartmann LC; Kalli KR; Oberg AL; Goode EL
Cancer Immunol Immunother; 2015 Dec; 64(12):1495-504. PubMed ID: 26298430
[TBL] [Abstract][Full Text] [Related]
44. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.
Deschoolmeester V; Baay M; Van Marck E; Weyler J; Vermeulen P; Lardon F; Vermorken JB
BMC Immunol; 2010 Apr; 11():19. PubMed ID: 20385003
[TBL] [Abstract][Full Text] [Related]
45. Impact of Single-organ Metastasis to the Liver or Lung and Genetic Mutation Status on Prognosis in Stage IV Colorectal Cancer.
Cavallaro P; Bordeianou L; Stafford C; Clark J; Berger D; Cusack J; Kunitake H; Francone T; Ricciardi R
Clin Colorectal Cancer; 2020 Mar; 19(1):e8-e17. PubMed ID: 31899147
[TBL] [Abstract][Full Text] [Related]
46. Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy.
Tokunaga R; Cao S; Naseem M; Lo JH; Battaglin F; Puccini A; Berger MD; Soni S; Millstein J; Zhang W; Stintzing S; Loupakis F; Cremolini C; Heinemann V; Falcone A; Lenz HJ
Clin Colorectal Cancer; 2019 Mar; 18(1):e8-e19. PubMed ID: 30293873
[TBL] [Abstract][Full Text] [Related]
47. Prevalence of PD-L1 expression is associated with EMAST, density of peritumoral T-cells and recurrence-free survival in operable non-metastatic colorectal cancer.
Watson MM; Lea D; Gudlaugsson E; Skaland I; Hagland HR; Søreide K
Cancer Immunol Immunother; 2020 Aug; 69(8):1627-1637. PubMed ID: 32314040
[TBL] [Abstract][Full Text] [Related]
48. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
[TBL] [Abstract][Full Text] [Related]
49. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.
Limsui D; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Harnack LJ; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
J Natl Cancer Inst; 2010 Jul; 102(14):1012-22. PubMed ID: 20587792
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological predictors of benefit from adjuvant chemotherapy for stage C colorectal cancer: Microsatellite unstable cases benefit.
Thomas ML; Hewett PJ; Ruszkiewicz AR; Moore JW
Asia Pac J Clin Oncol; 2015 Dec; 11(4):343-51. PubMed ID: 26471980
[TBL] [Abstract][Full Text] [Related]
51. Serotonin transporter gene (SLC6A4) variations are associated with poor survival in colorectal cancer patients.
Savas S; Hyde A; Stuckless SN; Parfrey P; Younghusband HB; Green R
PLoS One; 2012; 7(7):e38953. PubMed ID: 22911682
[TBL] [Abstract][Full Text] [Related]
52. Genetic variants in Hippo signalling pathway-related genes affect the risk of colorectal cancer.
Shen H; Meng Y; Hu T; Li S; Du M; Xin J; Gu D; Wang M; Fu Z
Arch Toxicol; 2021 Jan; 95(1):271-281. PubMed ID: 33011827
[TBL] [Abstract][Full Text] [Related]
53. Competing risks analysis of microsatellite instability as a prognostic factor in colorectal cancer.
Toh J; Chapuis PH; Bokey L; Chan C; Spring KJ; Dent OF
Br J Surg; 2017 Aug; 104(9):1250-1259. PubMed ID: 28401534
[TBL] [Abstract][Full Text] [Related]
54. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
[TBL] [Abstract][Full Text] [Related]
55. Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer.
Kim M; Grimmig T; Grimm M; Lazariotou M; Meier E; Rosenwald A; Tsaur I; Blaheta R; Heemann U; Germer CT; Waaga-Gasser AM; Gasser M
PLoS One; 2013; 8(1):e53630. PubMed ID: 23382847
[TBL] [Abstract][Full Text] [Related]
56. Poorly differentiated colorectal cancers: correlation of microsatellite instability with clinicopathologic features and survival.
Xiao H; Yoon YS; Hong SM; Roh SA; Cho DH; Yu CS; Kim JC
Am J Clin Pathol; 2013 Sep; 140(3):341-7. PubMed ID: 23955452
[TBL] [Abstract][Full Text] [Related]
57. Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry.
Jacobs ET; Martínez ME; Campbell PT; Conti DV; Duggan D; Figueiredo JC; Haile RW; LeRoy EC; Poynter JN; Thompson PA; Baron JA
Carcinogenesis; 2010 Aug; 31(8):1412-6. PubMed ID: 20558521
[TBL] [Abstract][Full Text] [Related]
58. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival.
Watson MM; Kanani A; Lea D; Khajavi RB; Søreide JA; Kørner H; Hagland HR; Søreide K
Ann Surg Oncol; 2020 Apr; 27(4):1058-1067. PubMed ID: 31686344
[TBL] [Abstract][Full Text] [Related]
59. A prospective analysis of microsatellite instability as a molecular marker in colorectal cancer.
Chang EY; Dorsey PB; Johnson N; Lee R; Walts D; Johnson W; Anadiotis G; Kiser K; Frankhouse J
Am J Surg; 2006 May; 191(5):646-51. PubMed ID: 16647353
[TBL] [Abstract][Full Text] [Related]
60. A Comprehensive Study of the Effect on Colorectal Cancer Survival of Common Germline Genetic Variation Previously Linked with Cancer Prognosis.
He Y; Timofeeva M; Li X; Din FVN; Blackmur JP; Vaughan-Shaw P; Svinti V; Farrington SM; Campbell H; Dunlop MG; Theodoratou E
Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1944-1946. PubMed ID: 31488414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
